Recent FDA Approvals in Leukemia and Lymphoma
Description
<span data-sheets-value= "{"1":2,"2":"
This week, we’ll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.
Coverage of stories discussed this week on ascopost.com:
FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML
FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma
To listen to more podcasts from ASCO, visit asco.org/podcasts.
<span data-sheets-value= "{"1":2,"2":"
This week, we’ll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.
Coverage of stories discussed this week on ascopost.com:
FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML
FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma
To listen to more podcasts from ASCO, visit asco.org/podcasts.
<span data-sheets-value= "{"1":2,"2":"
This week, we’ll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.
Coverage of stories discussed this week on ascopost.com:
FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML
FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma
To listen to more podcasts from ASCO, visit asco.org/podcasts.
<span data-sheets-value= "{"1":2,"2":"
This week, we’ll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.
Coverage of stories discussed this week on ascopost.com:
FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML
FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma
To listen to more podcasts from ASCO, visit asco.org/podcasts.
United States
